ADVANCED METASTATIC PANCREATIC CANCER
Clinical trials for ADVANCED METASTATIC PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED METASTATIC PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED METASTATIC PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets Hard-to-Treat tumors
Disease control Recruiting nowThis study tests an experimental drug called AZD9574, taken alone or with other anti-cancer medicines, in about 695 people whose advanced solid tumors have grown despite prior treatment. The main goals are to check the drug's safety and find the right dose. Researchers will also …
Matched conditions: ADVANCED METASTATIC PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New hope for tough pancreatic cancer: combo therapy with or without radiation
Disease control Recruiting nowThis study is for people with advanced pancreatic cancer that has spread and is no longer helped by first-line chemotherapy. It tests a mix of drugs (nal-IRI, 5-FU, leucovorin, benmelstobart, and anlotinib) with or without focused radiation (SBRT). The goal is to see if this comb…
Matched conditions: ADVANCED METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC